Antibody Opportunities
Antibodies are driving valuations at many public companies--and the aspirations of start-ups with new means of generating, tailoring and harnessing the proteins.
Antibodies are driving valuations at many public companies--and the aspirations of start-ups with new means of generating, tailoring and harnessing the proteins.